Table 1 Characteristics of persons who received one or more doses of HPV vaccine, 2008 - 2014

Total [N, (%^a)]

141,877 (83.8)

26,823 (15.8)

559 (0.3)

169,259

School year

2008/09

13,420

4,101

79

17,600 (10.4)

2009/10

25,693

4,554

708

30,355 (17.9)

2010/11

28,231

3,796

90

32,117 (19.0)

2011/12

28,971

3,787

79

32,837 (19.4)

2012/13

21,326

4,487

93

25,906 (15.3)

2013/14

24,236

6,098

110

30,444 (18.0)

Age in years

9

397

10

11

408 (0.2)

10^b

50,787

43

16

50,846 (30.0)

11^b

30,670

67

10

30,747 (18.2)

12

2,734

121

15

2,870 (1.7)

13

1,730

200

18

1,948 (1.2)

14^c

30,615

364

108

31,087 (18.4)

15^c

19,504

954

91

20,549 (12.1)

16

1,686

1,608

52

3,346 (2.0)

17

1,200

2,151

54

3,405 (2.0)

18

740

2,259

43

3,042 (1.8)

19

294

1,953

31

2,278 (1.3)

20

229

1,905

25

2,159 (1.3)

21 to 26

1,150

9,301

76

10,527 (6.2)

27 to 45

135

5,474

19

5,628 (3.3)

>45

4

413

0

417 (0.3)

Gender

Female

141,661

24,180

545

166,386 (98.3)

Male

216

2,643

14

2,873 (1.7)

Doses received

One dose

4,206

7,715

0

11,921 (7.0)

Two doses

9,599

6,316

47

15,962 (9.4)

Three doses

128,072

12,792

512

141,376 (83.5)

Rural/Urban Residence

Rural

29,446

3,804

163

33,413 (19.8)

Urban

112,431

23,019

396

135,846 (80.3)

Income quintile

Q1

27,716

3,556

100

31,372 (18.5)

Q2

28,184

4,664

106

32,954 (19.5)

Q3

25,515

5,089

91

30,695 (18.1)

Q4

30,991

6,591

140

37,722 (22.3)

Q5

29,471

6,923

122

36,516 (21.6)

Type of HPV vaccine

qHPV

141,851

25,141

536

167,528 (99.0)

bHPV

11

1,682

23

1,716 (1.0)

U/K^d

15

0

0

15 (0)